Medical research

New drug target for Ebola, Marburg viruses

Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these viruses—they ...

Cardiology

Levetiracetam may reduce anticoagulation effect of rivaroxaban

Levetiracetam, a commonly used medication to prevent seizures, may reduce the anticoagulation effect of oral rivaroxaban in humans. As such, clinicians should measure direct oral anticoagulant plasma levels during treatment. ...

Diseases, Conditions, Syndromes

Lassa virus' soft spot revealed

As this year's Lassa fever outbreak in Nigeria is finally ebbing, the total tally came to more than 600 infected people, one-quarter of them dead. Thousands more die each year, uncounted in rural villages throughout West ...

Diseases, Conditions, Syndromes

Viral decoys—how the Ebola virus leads the immune system astray

A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system. The virus causes infected cells to release decoys that inactivate ...

Immunology

Viral protein may help chickenpox virus spread within the body

The virus that causes chickenpox—varicella zoster virus (VZV)—possesses a protein that could enhance its ability to hijack white blood cells and spread throughout the body, according to new research published in PLOS ...

page 2 from 4